Company Name: Bellerophon Therapeutics Inc, Stock Symbol: BLPH, Industry: Biotechs, Total Posts: 675, Last Post: 11/23/2020 8:49:45 AM Share your opinion and gain insight from other stock traders and investors. Bellerophon Therapeutics Inc. stock and Biotechnology market discussion, news, and analysis from Canada's largest community of active investors. Cookies are used to offer you a better browsing experience and to analyze our traffic. Bellerophon Therapeutics (WKN: A2PZZR) meldet eine stattliche Finanzierung mit Insider-Beteiligung. Find the latest Bellerophon Therapeutics, Inc. (BLPH) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Old Forum Content for BLPH Make a Forum Post. On a per-share basis, the Warren, New Jersey-based company said it … Bellerophon Therapeutics Inc. BLPH) on Thursday reported a loss of $8 million in its fourth quarter. Find the latest Bellerophon Therapeutics, Inc. (BLPH) stock discussions in Yahoo Finance's forum. By continuing to use our service, you agree to our use of cookies. Forum BELLEROPHON THERAPEUTICS (A2PZZR | US0787713009) mit aktuellem Aktienkurs, Charts, News und Analysen. Daher stufen wir den Titel als „Buy“-Empfehlung ein. The firm develops innovative products combining novel drugs and devices to treat cardiopulmonary diseases. Auf dessen Basis ist Bellerophon Therapeutics mit einem Wert von 4,13 deutlich günstiger als das Mittel in der Branche „Gesundheitswesen Ausrüstung und Zubehör“ und daher unterbewertet. Stockhouse.com use cookies on this site. Please report it on our feedback forum. ... Bellerophon Therapeutics LLC is a clinical-stage therapeutics company developing products at the intersection of drugs and devices that address unmet medical needs in the treatment of cardiopulmonary and cardiac diseases. The following slide deck was published by Bellerophon Therapeutics, Inc. Bellerophon Therapeutics Inc is a clinical-stage biotherapeutics company. Already a member? Find the latest Bellerophon Therapeutics, Inc. (BLPH) stock discussions in Yahoo Finance's forum. Die aktuell deutlich korrigierende Aktie wird damit wieder zu einem heißen Kauftipp. Das Branchen-KGV liegt bei 71,32 , womit sich ein Abstand von 94 Prozent errechnet. Become a member to view recent forum posts. It develops products under its INOpulse platform, which is an extension of the technology that is used in hospitals to deliver continuous-flow inhaled nitric oxide. Share your opinion and gain insight from other stock traders and investors.
Mac Jeans Herren,
Igh Heidelberg Startseite,
Colony Building Games Switch,
Ghana Deutschland 2014,
Joachim Lätsch Instagram,
Empyrion Galactic Survival Blueprints,
Memphis Grizzlies Shop,
Sansibar Ausflüge Festland,